v3.26.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Income Statement [Abstract]    
Revenues $ 0 $ 0
Operating expenses 13,312,000 1,385,000
Research and development expenses 1,611,000 191,000
Loss from operations (14,923,000) (1,576,000)
Interest and financing expense (389,000) (358,000)
Other 7,000 0
Net Loss $ (15,305,000) $ (1,934,000)
Net loss per common share, basic $ (0.03) $ (0.00)
Net loss per common share, diluted $ (0.03) $ (0.00)
Weighted average common shares outstanding, basic 499,682,276 404,977,565
Weighted average common shares outstanding, diluted 499,682,276 404,977,565